Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 5
2012 1
2013 1
2014 3
2015 1
2017 1
2018 1
2020 1
2021 2
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
Khobragade A, Bhate S, Ramaiah V, Deshpande S, Giri K, Phophle H, Supe P, Godara I, Revanna R, Nagarkar R, Sanmukhani J, Dey A, Rajanathan TMC, Kansagra K, Koradia P; ZyCoV-D phase 3 Study Investigator Group. Khobragade A, et al. Among authors: sanmukhani j. Lancet. 2022 Apr 2;399(10332):1313-1321. doi: 10.1016/S0140-6736(22)00151-9. Lancet. 2022. PMID: 35367003 Free PMC article. Clinical Trial.
Epilepsy: Novel therapeutic targets.
Anovadiya AP, Sanmukhani JJ, Tripathi CB. Anovadiya AP, et al. Among authors: sanmukhani jj. J Pharmacol Pharmacother. 2012 Apr;3(2):112-7. doi: 10.4103/0976-500X.95505. J Pharmacol Pharmacother. 2012. PMID: 22629084 Free PMC article.
Five cases of Jatropha curcas poisoning.
Shah V, Sanmukhani J. Shah V, et al. Among authors: sanmukhani j. J Assoc Physicians India. 2010 Apr;58:245-6. J Assoc Physicians India. 2010. PMID: 21046881
Ethics in clinical research: the Indian perspective.
Sanmukhani J, Tripathi CB. Sanmukhani J, et al. Indian J Pharm Sci. 2011 Mar;73(2):125-30. doi: 10.4103/0250-474x.91564. Indian J Pharm Sci. 2011. PMID: 22303053 Free PMC article.
Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial.
Sarkar S, Bokade C, Garg K, Kumar R, Sanmukhani J, Mittal R. Sarkar S, et al. Among authors: sanmukhani j. Hum Vaccin Immunother. 2021 Mar 4;17(3):681-689. doi: 10.1080/21645515.2020.1794683. Epub 2020 Aug 26. Hum Vaccin Immunother. 2021. PMID: 32845782 Free PMC article. Clinical Trial.
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India.
Momin T, Kansagra K, Patel H, Sharma S, Sharma B, Patel J, Mittal R, Sanmukhani J, Maithal K, Dey A, Chandra H, Rajanathan CT, Pericherla HP, Kumar P, Narkhede A, Parmar D. Momin T, et al. Among authors: sanmukhani j. EClinicalMedicine. 2021 Aug;38:101020. doi: 10.1016/j.eclinm.2021.101020. Epub 2021 Jul 17. EClinicalMedicine. 2021. PMID: 34308319 Free PMC article.
20 results